Search - tctmd.com

Displaying 521 - 540 of 734

Sort: Relevancy | Date

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

News Daily News

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Michael O'Riordan

April 14, 2017

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Daily News

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Michael O'Riordan

April 07, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Todd Neale

April 04, 2017

Presentation ECHO 2017

Mechanical Complications of MI: Case Ilustrations

Presenter: Michael H. Picard

April 01, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Daily News

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

Todd Neale

March 27, 2017

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

News Conference News ACC 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

Advertisement

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

One in Five Acute MI Patients Drop Statins Within 2 Years

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Physically Active Less Likely to Die After MI Than Sedentary Individuals

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Absorb BVS Use Restricted in Europe

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Mechanical Complications of MI: Case Ilustrations

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Hospital-Level PCI Volume May Not Have a Strong Influence on Outcomes, UK Study Suggests

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content